CDK2 antibody
Quick Overview for CDK2 antibody (ABIN2470565)
Target
See all CDK2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- Recognizes cdk2, Mr 33kD. Does not cross-react with other cdks.
-
Purification
- Protein G Column
-
Immunogen
- CDK2 monoclonal antibody was raised against recombinant CDK2 (Human).
-
Isotype
- IgG
-
-
-
-
Application Notes
- CDK2 antibody can be used in immunohistochemistry starting at 10 μg/mL.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1M Tris-glycine, pH 7.4, 0.15M sodium chloride, 0.05 % sodium azide, before the addition of glycerol to 30 %
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- As with all antibodies avoid freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store CDK2 antibody at 4 °C or -20 °C.
-
-
- CDK2 (Cyclin-Dependent Kinase 2 (CDK2))
-
Alternative Name
- CDK2
-
Background
- Cyclin-dependent kinase 2 (CDK2), a CDC2/CDK-type protein kinase, regulates cell-cycle transition from G1 to S phase. CDK2 activation requires formation of a heterodimer with cyclin A, D, or E and phosphorylation by CAK. CDK2 inhibition results from association with p21Cip1 (CDKN1A) and p27Kip1 (CDKN1B). Two alternatively spliced variants and multiple transcription initiation sites have been reported. Inhibition of CDK2 has been suggested to help prevent chemotherapy-induced alopecia in cancer patients.
-
Gene ID
- 1017
-
UniProt
- P24941
-
Pathways
- PI3K-Akt Signaling, Cell Division Cycle, Mitotic G1-G1/S Phases, DNA Replication, M Phase, Synthesis of DNA
Target
-